Covered recipient · General Payments record
KENNETH L VETTEL
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$611.96
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $181.20 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $48.75 | 2 |
| Novo Nordisk AS | $48.36 | 3 |
| Acerta Pharma LLC | $27.41 | 1 |
| Exact Sciences Corporation | $21.95 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.14 | 1 |
| Janssen Pharmaceuticals, Inc | $14.59 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.41 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106282346 | CMS |
| ABBVIE INC. | $15.34 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106282348 | CMS |
| AstraZeneca Pharmaceuticals LP | $27.41 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104207761 | CMS |
| Exact Sciences Corporation | $21.95 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114941294 | CMS |
| Janssen Pharmaceuticals, Inc | $14.59 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078085346 | CMS |
| Novo Nordisk Inc | $16.24 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097107941 | CMS |
| Novo Nordisk Inc | $13.77 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097558513 | CMS |
| Novo Nordisk Inc | $18.35 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096713121 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.14 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118999825 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.